PerkinElmer Inc, which helps laboratories improve human and environmental health with instruments, accessories, reagents, consumables, software, etc, has sold its US prenatal screening laboratory services business PerkinElmer Labs/NTD (NTD) to Eurofins Scientific. NTD generated approximately $20 million in revenue in 2015.
“Recent changes to US healthcare reform continue to drive the consolidation of diagnostics testing towards broader service providers. Eurofins, with its breadth of testing services and capabilities, is uniquely positioned to meet the expanding service needs of NTD's customers. Furthermore, the divestiture of the NTD business allows PerkinElmer to concentrate its efforts on developing innovative maternal fetal health technologies and solutions for the US. Outside the US, we will continue to provide kits, technologies and services through a variety of channels focused on improving health outcomes for babies and expectant mothers,” said Prahlad Singh, president - diagnostics, PerkinElmer.
PerkinElmer offers a comprehensive portfolio of diagnostic solutions including: prenatal, neonatal and infectious disease screening, along with molecular diagnostics, through its wide range of instruments, reagents and assay platforms, and software offerings. PerkinElmer also provides private cord blood and cord tissue preservation to families through ViaCord Llc.
